Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation

Published:2018-09-03 Issue:6 Volume:38 Page:822-837
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Lin Yi-Pei,Wu Jun-I,Tseng Chien-Wei,Chen Huei-Jane,Wang Lu-Hai

Funder

National Health Research Institutes (NHRI)

Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0471-1.pdf

Reference74 articles.

1. Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: toward strengthening the critical relationship. Am J Surg Pathol. 2016;40:e94–102.

2. Popper HH. Progression and metastasis of lung cancer. Cancer Metastas. 2016;35:75–91.

3. Uramoto H, Tanaka F. Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res. 2014;3:242–9.

4. Kalemkerian GP. Combination chemotherapy for relapsed small-cell lung cancer. Lancet Oncol. 2016;17:1033–5.

5. Teleki I, Szasz AM, Maros ME, Gyorffy B, Kulka J, Meggyeshazi N, et al. Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis. PLoS ONE. 2014;9:e112541.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay between paclitaxel, gap junctions, and kinases: unraveling mechanisms of action and resistance in cancer therapy;Molecular Biology Reports;2024-03-29

2. Gap junction beta‐4 accelerates cell cycle progression and metastasis through MET–AKT activation in pancreatic cancer;Cancer Science;2024-02-11

3. Cell Death, by Any Other Name…;Cells;2024-02-10

4. Sex disparities in non-small cell lung cancer: mechanistic insights from a cRaf transgenic disease model;eBioMedicine;2023-09

5. Multi-omics analysis of expression profile and prognostic values of connexin family in LUAD;Journal of Cancer Research and Clinical Oncology;2023-07-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3